Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
EcoR1 Capital

EcoR1 Capital

An investment management and venture capital firm that was founded in 2012 and headquartered in San Francisco, California investing in science-based technology companies.

EcoR1 Capital is a San Francisco-based venture capital company that also offers investment management services. It is named after the restriction enzyme of the same name that led to major advances in the biomedical field. It states that it focuses on biomedical companies that are developing treatments for untreated diseases.

The firm invests in both early and late-stage funding rounds for its portfolio companies. It has made more than 41 investments and has had 24 exits. EcoR1 Capital raised three funds between 2017 and 2019, totaling more than $400 million.

Timeline

Invested in

Patents

Funding Rounds Participated In

Further Resources

Title
Author
Link
Type
Date

Institutional Top Ideas: EcoR1 Capital

Jonathan Faison

Web

June 12, 2018

News

Title
Author
Date
Publisher
Description
FinSMEs
June 1, 2021
FinSMEs
About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter FinSMEs.com by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.

References

Golden logo
By using this site, you agree to our Terms & Conditions.